相关实验视频

Updated: Jan 6, 2026

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice

Published on: March 2, 2019

甲调节巨细胞活动,并增强细菌清除在Pseudomonas aeruginosa急性肺炎

Thiago Caetano Andrade Belo¹, Natália Cristina de Melo Santos¹, Leonardo Pereira de Araújo¹

¹Laboratory of Molecular Biology of Microorganisms, Federal University of Alfenas (UNIFAL), Rua Gabriel Monteiro da Silva, 700, Alfenas, Minas Gerais, 37130-001, Brazil.

Molecular and cellular biochemistry

|October 22, 2025

概括

艾弗梅克丁与MD-2分子结合,抑制了体外巨细胞的活性. 然而,在体内,特别是TLR4缺乏的小鼠中,艾弗梅克丁增强了细菌清除和调节肺炎,揭示了复杂的免疫调节作用.

科学领域:

免疫学免疫学免疫学
微生物学微生物学
药理学药理学是指药理学的学科.

背景情况:

收费类受体4 (TLR4) 和它的共同受体MD-2对于识别格拉姆阴性细菌中的脂多糖 (LPS) 是至关重要的.
众所周知,甲可以提高LPS挑战小鼠的生存率,但其确切的免疫机制尚不清楚.

研究的目的:

在TLR4信号传递和Pseudomonas aeruginosa感染的背景下调查ivermectin在,体外和体内免疫调节机制.

主要方法:

在基分子对接中评估ivermectin与TLR4/MD-2的结合.
在体外研究中,使用用LPS刺激或感染P. aeruginosa的巨细胞,有或没有ivermectin和TLR4/MD-2抑制剂.
在野生类型和TLR4淘汰赛小鼠感染P. aeruginosa并用ivermectin治疗的体内研究.

主要成果:

艾弗梅克丁证明了与MD-2结合的高亲和力.
在体外,ivermectin降低了细菌清除和改变了细胞因子的产生 (减少了NO,TNF-α;增强了NF-κB).
在体内,艾弗梅克丁降低了细菌负载和肺炎,特别是在TLR4淘汰赛小鼠中,改善了他的病理学和细胞因子概况 (降低IL-6,TNF-α;增加IL-17,IFN-γ).

结论:

艾弗梅克丁与MD-2结合,并在体外抑制了巨细胞的杀菌活性.
在体内,ivermectin表现出上下文依赖的免疫调节作用,改善细菌清除和肺病理,特别是在没有TLR4信号的情况下.

关键词:

我从来没有使用过mectin.巨细胞是一个巨细胞.在TLR4/MD-2中.

更多相关视频

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

相关概念视频

Gene Regulation in Microbial Communities: Quorum Sensing

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...